Therefore, we analyzed SKA2 protein expression using Western blotting, and performed co-IPs and subsequent capillary-based immune analysis to explore SEC22B to SNAP29 binding in the hippocampus of a cohort of AD cases (n = 7) and age matched controls (n = 13) (Supplementary Data 10). Here, SNAP29 is linked to Alzheimer disease.